Brief Summary

Expanded access requests for AMG 701 may be considered for adult patients with relapsed and/or refractory multiple myeloma whose disease is in partial response or better after AMG 420 therapy. To request access, use Responsible Party contact information provided in this record.

Available
Individual Patients

Drug: AMG 701

Eligibility Criteria

Inclusion Criteria:

-

Exclusion Criteria:

-

Eligibility Gender
All
Contacts

Amgen Call Center
866-572-6436
medinfo@amgen.com

MD
Study Director
Amgen

NCT Number